BOLT vs EIX
Bolt Biotherapeutics (BOLT) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
BOLT currently screens at market cap $11.3M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the BOLT and EIX stock pages for the full models.
Not investment advice.